Advertisement
Original Article| Volume 64, ISSUE 5, P429-437, November 2022

Psycho-Existential Symptom Assessment Scale (PeSAS) Screening in Palliative Care

Open AccessPublished:August 08, 2022DOI:https://doi.org/10.1016/j.jpainsymman.2022.08.002

      Abstract

      Context

      Psycho-existential symptoms are common yet often missed or neglected in palliative care. Screening can be an effective way to recognize and respond to this need.

      Objectives

      We aimed to implement routine use of the Psycho-existential Symptom Assessment Scale (PeSAS) as a screening tool in Australian palliative care services and discern the symptom prevalence identified.

      Methods

      In a multi-site rolling design, we established implementation site committees and embarked on experiential workshops to train clinicians in the tool's efficient use. Patient symptom prevalence data were collected to compare uptake across sites. Descriptive statistics were applied.

      Results

      Over one year, we trained 216 clinicians across six palliative care services in the use of the PeSAS as a screening tool and collected data from 1405 patients. Clinicians reported significant growth in their sense of efficacy in assessing psycho-existential wellness. Services using electronic records implemented most easily. Psycho-existential symptoms with clinically significant prevalence (scores ≥ 4/10) included anxiety 41.1%, discouragement 37.6%, hopelessness 35.8%, pointlessness 26.9%, depression 30.3%, and the wish to die 17%. The precision of measurement within 3% was found for severe ratings (score ≥ 8/10) including anxiety 10.6%, depression 10.2%, the wish to die 7.6%, and confusion 3.6%.

      Conclusion

      Clinicians can be trained to screen with the Psycho-existential Symptom Assessment Scale, which serves as a valuable measure to better recognize symptoms of psycho-existential distress among palliative care patients. Implementation barriers included the prior ethos of the service, confidence in talking about these themes, electronic data entry, and perceived time pressures.

      Key Words

      Key Message

      Because psycho-existential states including anxiety, depression, demoralization and the wish to die can remain unaddressed by palliative care services, implementation of a standard screening tool for psycho-existential symptoms is recommended. Over one third of palliative care patients report significant prevalences of these symptoms.

      Introduction

      Unidentified and unaddressed psycho-existential symptoms cause patient suffering, poor quality of life, vulnerability, suicidal thinking, and lead to acute admissions.
      • Kissane DW
      Education and assessment of psycho-existential symptoms to prevent suicidality in cancer care.
      These symptoms generate comparable hospitalizations to those needed to manage physical symptoms, a substantial health cost. They also create a societal burden, contributing to caregiver burnout, poor coping, and increased community services.
      • Kissane DW
      Education and assessment of psycho-existential symptoms to prevent suicidality in cancer care.
      Fortunately, several evidence-based, medication and counselling approaches are available to help, but these remain underutilized in palliative care.
      • Vehling S
      • Kissane DW.
      Existential distress in cancer: Alleviating suffering from fundamental loss and change.
      An old wisdom states, “More mistakes are made in medicine by not looking than not knowing.” This adage is especially true for psychological and existential states, as research across 20 years has shown how depression has inadvertently passed untreated.
      • Walker J
      • Holm Hansen C
      • Martin P
      • et al.
      Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.
      ,
      • Kissane DW
      Unrecognized and untreated depression in cancer care.
      One response was the introduction of psychosocial distress screening
      • Jacobsen PB
      • Donovan KA
      • Trask PC
      • et al.
      Screening for psychologic distress in ambulatory cancer patients.
      through the National Comprehensive Cancer Network clinical practice guidelines.
      • Holland JC
      • Bultz BD.
      National Comprehensive Cancer Network (NCCN). The NCCN guideline for distress management: a case for making distress the sixth vital sign.
      The Commission on Cancer of the American College of Surgeons also published patient-centered accreditation standards that included palliative care.
      • Fashoyin-Aje LA
      • Martinez KA
      • Dy SM.
      New patient-centered care standards from the Commission on Cancer: opportunities and challenges.
      Gradual uptake of distress screening occurred, although “not all were using the problem list that accompanies” the Distress Thermometer (DT).
      • Lazenby M
      • Ercolano E
      • Grant M
      • et al.
      Supporting Commission on Cancer-mandated psychosocial distress screening with implementation strategies.
      ,p.e415 A dedicated education program improved uptake,
      • Lazenby M
      • Ercolano E
      • Knies A
      • et al.
      Psychosocial distress screening: an educational program's impact on participants’ goals for screening implementation in routine cancer care.
      while recently the DT was validated in the UK for patients with advanced cancer receiving specialist palliative care in a hospice setting.
      • Graham-Wisener L
      • Dempster M
      • Sadler A
      • et al.
      Validation of the Distress Thermometer in patients receiving specialist palliative care in a hospice setting.
      However, the problem list that accompanies the DT omits existential concerns relevant for palliative care.
      • Clover KA
      • Oldmeadow C
      • Nelson L
      • et al.
      Which items on the distress thermometer problem list are the most distressing?.
      Palliative care has used the Edmonton Symptom Assessment Scale (ESAS) as a standard tool for measuring key symptoms.
      • Bruera E
      • Kuehn N
      • Miller MJ
      • Selmser P
      • Macmillan K.
      The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients.
      Through use of a visual analogue scale (0–10), Bruera et al. promoted both assessment and subsequent monitoring of these common symptoms. Across 25 years, use of the ESAS has helped our understanding of symptom trajectories, clusters and modulating factors.
      • Hui D
      • Bruera E.
      The Edmonton Symptom Assessment System 25 years later: past, present and future developments.
      The introduction of a national benchmarking program in palliative care in Australia
      • Agar K
      • Watters P
      • Currow DC
      • Aoun SM
      • Yates P.
      The Australian Palliative Care Outcomes Collaboration (PCOC) – measuring the quality and outcomes of palliative care on a routine basis.
      led to use of a modified Symptom Assessment Scale,
      • Daveson BA
      • Allingham SF
      • Clapham S
      • et al.
      The PCOC Symptom Assessment Scale (SAS): a valid measure for daily use at point of care and in palliative care programs.
      which excluded symptoms such as anxiety and depression. Thus, clinicians bypassed screening for these, perhaps because of management complexity and lack of confidence about how to respond. Moreover, a systematic review of 152 assessment tools used in palliative care revealed the relative paucity of tools assessing spiritual and existential domains.
      • Aslakson RA
      • Dy SM
      • Wilson RF
      • et al.
      Patient- and caregiver-reported assessment tools for palliative care: summary of the 2017 Agency for Healthcare Research and Quality Technical Brief.
      Substantial observational work has occurred in patients with advanced illness examining existential distress as a dimension of quality of life,
      • Cohen SR
      • Mount BM
      • Tomas JJ
      • Mount LF.
      Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire.
      including the mental state of demoralization,
      • Kissane DW
      Demoralization – A life-preserving diagnosis to make in the severely medically ill.
      which involves lowered morale and poor coping, and can lead to hopelessness, pointlessness, sense of failure and a desire to give up on life.
      • Robinson S
      • Kissane DW
      • Brooker J
      • Burney S.
      A review of the construct of demoralization: history, definitions, and future directions for palliative care.
      Early observations by Morita et al. in Japan
      • Morita T
      • Kawa M
      • Honke Y
      • et al.
      Existential concerns of terminally ill cancer patients receiving specialized palliative care in Japan.
      highlighted the prominence of existential distress. Four systematic reviews of studies assessing demoralization in palliative care have revealed prevalences that include 13%–18% in 2295 patients using the validated Demoralization Scale (DS),
      • Robinson S
      • Kissane DW
      • Brooker J
      • Burney S
      A systematic review of the Demoralization Syndrome in individuals with progressive disease and cancer: a decade of research.
      20%–33% in 959 patients using a demoralization interview,
      • Tecuta L
      • Tomba E
      • Grandi S
      • Fava GA.
      Demoralization: a systematic review on its clinical characterization.
      18.3% in 1279 cancer patients using the DS,
      • Tang PL
      • Wang HH
      • Chou FH.
      A systematic review and meta-analysis of demoralization and depression in patients with cancer.
      and 24%–35% in 11,670 oncology and non-oncology patients across 52 more recent studies.
      • Gan LL
      • Gong S
      • Kissane DW.
      Mental state of demoralisation across diverse clinical settings: A systematic review, meta-analysis and proposal for its use as a ‘specifier’ in mental illness.
      The validation of the DS,
      • Kissane DW
      • Wein S
      • Love A
      • Lee XQ
      • Kee PL
      • Clarke DM.
      The Demoralization Scale: a preliminary report of its development and preliminary validation.
      refined DS-II,
      • Robinson S
      • Kissane DW
      • Brooker J
      • et al.
      Refinement and revalidation of the Demoralization Scale: the DS-II ‒ internal validity.
      ,
      • Robinson S
      • Kissane DW
      • Brooker J
      • et al.
      Refinement and revalidation of the Demoralization Scale: the DS-II ‒ external validity.
      brief 6 item DS-6,
      • Belvederi Murri M
      • Zerbinatia L
      • Ounallia H
      • et al.
      Assessing demoralization in medically ill patients: Factor structure of the Italian version of the demoralization scale and development of short versions with the item response theory framework.
      and Demoralization Interview

      Bobevski I, Kissane DW, McKenzie D, et al. The Demoralization Interview: reliability and validity of a new brief diagnostic measure. Under review

      underpinned the development of the Psycho-existential Symptom Assessment Scale (PeSAS) as a screening tool to better identify psycho-existential distress. In this study, following the model used for the ESAS, we aimed to implement the routine use of the PeSAS among our palliative care services, in the process observing the prevalence of these symptoms and training multidisciplinary teams to respond appropriately.

      Development of the Psycho-existential Symptom Assessment Scale (PeSAS)

      Here, we briefly review the prior development of the PeSAS. For inclusion in a screening tool, symptoms need to be important, burdensome, worrying, and disabling. Furthermore, for routine assessment, symptoms must occur commonly. Three statistical approaches were used to identify the most helpful psycho-existential symptoms to screen for.
      Firstly, using the Demoralization Scale alongside the Demoralization Interview
      • Fava GA
      • Freyberger HJ
      • Bech P
      • et al.
      Diagnostic criteria for use in psychosomatic research.
      as a gold standard for the presence of demoralization, we found comparable areas under the curve (AUC) and sensitivity and/or specificity between 24 items (AUC 0.821, sensitivity 76.7%, specificity 72.8%) and 6 items (AUC 0.810, sensitivity 75.7%, specificity 71.7%).
      • Belvederi Murri M
      • Zerbinatia L
      • Ounallia H
      • et al.
      Assessing demoralization in medically ill patients: Factor structure of the Italian version of the demoralization scale and development of short versions with the item response theory framework.
      This generated support that a brief form of six items is valid.
      Secondly, the probability that a particular symptom was present among patients with psycho-existential morbidity was assessed in 1527 cancer patients.
      • Bobevski I
      • Kissane DW
      • Vehling S
      • McKenzie D
      • Glaesmer H
      • Mehnert A.
      Latent class analysis differentiation of adjustment disorder and demoralization, more severe depressive-anxiety disorders, and somatic symptoms in a cohort of patients with cancer.
      For those with severe psychopathology, the probability of endorsing pointlessness was 80%, feeling trapped 77%, suicidal 76%, loss of control 75%, anxiousness 74%, hopelessness 68%, and lowered mood 52%. For those with moderate psychopathology, the probability of symptoms being endorsed was 69% for feeling trapped, 66% pointlessness, 50% hopelessness, and 42% loss of control. Restated simply, these probabilities make these symptoms worthwhile screening targets.
      Thirdly, we used the strength of associations between symptoms in a network analysis to discern which symptoms form communities of related symptoms, and which were most central to each community.
      • Belvederi Murri M
      • Caruso R
      • Ounalli H
      • et al.
      The relationship between demoralization and depressive symptoms among patients from the general hospital: network and exploratory graph analysis.
      This approach revealed four symptom clusters: firstly, that feeling trapped and becoming discouraged/distressed were strongly correlated; secondly, a cluster of pointlessness, hopelessness and a desire to die; thirdly, a cluster of the symptoms of anhedonic depression; and finally, a cluster involving loss of control and self-worth, where roles were lost and non-specific emotional symptoms predominated. This network analysis was replicated in a separate dataset,
      • Bobevski I
      • Kissane DW
      • Vehling S
      • Mehnert-Theuerkauf A
      • Belvederi Murri M
      • Grassi L
      Demoralization and its link with depression, psychological adjustment and suicidality among cancer patients: A network psychometrics approach.
      and confirmed that discouragement, entrapment, hopelessness, pointlessness, loss of control, loss of roles and desire to die were key symptoms to screen for.
      These different methodological approaches demonstrated convergence towards the same brief group of symptoms as screening targets. Furthermore, the inclusion of anxiety and depression as in the ESAS has a long body of scholastic support, while confusion as a marker of cognitive impairment or delirium/dementia syndromes seemed essential. The resultant screening tool, the Psycho-existential Symptom Assessment Scale (PeSAS), is illustrated in Appendix 1; the optimal ordering of symptoms was tested for patient comfort and comprehension through several iterations. Rather than offer definitions of any symptom, we confirmed that patient understanding was best achieved through the introduction of a couple of synonyms that clarified the meaning of a particular symptom. Illustrative synonyms are shown in Table 1.
      Table 1Synonyms Used by Clinicians to Promote Understanding of Screening Items
      PeSAS SymptomCommon Symptom Synonyms
      AnxietyWorry, Nervous, Restless
      DiscouragementLow morale, disheartened, low confidence
      Trapped by illnessStuck, feeling blocked
      HopelessnessNo future, pessimistic, loss of hope
      PointlessnessNo meaning, no purpose, no value to life
      Loss of controlNot in charge, helpless, can't plan
      Loss of rolesPartner, parent, job, loss of identity or self-worth
      DepressionSad, low mood, no interest, joy or pleasure
      Wish to dieNot go on, want to end it, opposite of wish to live, suicidal thoughts
      ConfusionPoor memory, disoriented, delirious, confused about things

      Methodology

      Overview

      Using an implementation framework,
      • Glasgow RE
      • Vinson C
      • Chambers D
      • Khoury MJ
      • Kaplan RM
      • Hunter C.
      National Institutes of Health approaches to dissemination and implementation science: current and future directions.
      ,
      • Tabak RG
      • Khoong EC
      • Chambers DA
      • Brownson RC.
      Bridging research and practice: models for dissemination and implementation research.
      graduated roll out across successive services was planned. The project was introduced to a site implementation committee, following which experiential training workshops were conducted using role play with simulated patients to train staff to conduct PeSAS screening. An electronic version of PeSAS was available through an electronic medical record or web-based app. Patient data were uploaded by sites to a central data manager for comparative evaluation. Local implementation committees monitored barriers. The implementation model is illustrated in Fig. 1.
      Fig 1
      Fig. 1Model of implementation for Psycho-existential Symptom Assessment scale (PeSAS): a dynamic interaction occurs between national and local site teams, training and supervision, and outcome measurement.

      Ethical Approval

      Approval was received from the Human Research and Ethics Committees of all participating institutions.

      Sample and Settings

      As part of a national implementation program, this study reports on year one of the introduction of PeSAS screening to six palliative care services in Victoria, New South Wales and Australian Capital Territory during 2021. These services represent a blend of inpatient, consultation and community programs and differ in size and staffing numbers. Numbers of clinicians trained by discipline and sociodemographic characteristics are in Table 2; services are deidentified.
      Table 2Clinicians’ Socio-Demographic Characteristics by Discipline and Across Contributory Services, Showing Distribution of Disciplines and Eventual Patient Numbers Screened by Services
      CharacteristicsConsultants PhysiciansTrainee PhysiciansNursesPsychosocial StaffPastoral CareTotal TrainedPatient numbers screened
      Age ranges

      % 20–29 years

      % 30–49 years

      % >50 years


      0.0

      84.6

      15.4


      42.9

      57.1

      0.0


      8.3

      49.2

      42.4


      11.8

      41.2

      47.1


      0.0

      25.0

      75.0


      216
      Clinical Experience

      Mean in years

      (Range)


      16.0

      (8–40)


      6.8

      (1–24)


      17.1

      (1–50)


      13.6

      (1–50)


      16.4

      (7–25)


      216
      Religion %

      % Christian

      % Atheist

      % Other


      41.7

      25.0

      33.3


      35.7

      42.9

      21.4


      47.6

      21.8

      30.6


      34.4

      28.1

      37.5


      85.7

      0.0

      14.3


      216
      Country of Birth

      % Australian

      % European

      % Other


      16.7

      25.0

      58.3


      42.9

      14.3

      42.9


      46.9

      19.2

      33.8


      70.6

      8.8

      20.6


      100.0

      0.0

      0.0


      216
      Clinician profile for de-identified servicesPatients n
      Service A38361149323
      Service B36205135226
      Service C3223102949
      Service D00024529625
      Service E2219102470
      Service F38362150112
      TOTAL14261343482161405

      Procedures

      Program Establishment at Sites

      Each site leader convened a multidisciplinary implementation committee and identified local site champions and a research data nurse. The rationale for psycho-existential screening was introduced with the implementation plan. Site committees selected the components of a service to initially engage with (inpatient, consult or community program).

      Training

      Training workshops (3 hour, groups of 8–12 staff) were conducted, training between 30 and 50 staff per site. Workshops comprised presentation of introductory principles, demonstration videos, fishbowl role play exercises, feedback discussion and review of management principles.
      Clinicians were trained to obtain symptom scores in two to three minutes, to summarize the 2–3 most elevated scores and empathize with elicited distress. They were instructed to explore the “four P's” of assessment: what precipitated, predisposed to, perpetuated, or protected against these symptoms. Participants were advised on how to seek permission to discuss scores with the multidisciplinary team and effect referral for additional psychosocial support.
      Training included an overview of symptom management, including treatment of anxiety and depression. Postures of existential vulnerability were contrasted with postures of resilience, so that clinicians could appreciate how to promote optimal adaptation. Risk assessment for suicidal patients and development of management plans were covered. Participants were given a booklet summarizing all that was taught.

      Introduction of Screening

      Screening was launched at components of each service (e.g., inpatient, community) as patients were admitted. It was introduced as part of routine clinical activity and embedded into the performa used for history taking and examination of each assessed patient. This was reflective of our concern for psychological coping as part of our interest in the whole person. Completion of PeSAS using available software was encouraged. Clinicians incorporated PeSAS scores into discussions of goals of care held by multidisciplinary teams. Follow-up scoring was repeated as clinically indicated. Patients were ineligible if confused, had an altered conscious state, had days to live, or when language was a barrier.

      Data Collection

      Clinician data: Pre-workshop data included the discipline of the clinician, age band and years of experience, gender, country of birth, and religious affiliation. Pre and post workshop data included ratings of perceived confidence (0–10) in assessing physical, psycho-existential and suicidal symptoms, empathic responsiveness, making a psychiatric diagnosis, managing distress and effecting psychosocial referral. Post-workshop data also included perceptions of new skill development, review of communication skills and likelihood of enhanced quality of care provision.
      Service data: Services were deidentified through the use of letters A to F. Basic data included implementation committee minutes, number of workshops, total clinicians trained, and follow-up supervision and case discussions.
      Patient data: A minimal patient dataset included phase of illness as described by the Palliative Care Outcomes Collaboration,
      • Agar K
      • Watters P
      • Currow DC
      • Aoun SM
      • Yates P.
      The Australian Palliative Care Outcomes Collaboration (PCOC) – measuring the quality and outcomes of palliative care on a routine basis.
      functional status using the Australian Karnofsky score (AKPS),
      • Abernethy AP
      • Shelby-James T
      • Fazekas BS
      • Woods D
      • Currow DC
      The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481].
      and PeSAS symptom scores.

      Data Analysis

      Deidentified aggregate clinician data by service compared their pre-and post-workshop efficacy ratings in the use of the PeSAS screening tool. Aggregate patient data enabled symptom prevalence computation as frequencies, while the precision of measurement was represented by the difference in 95% confidence intervals. T-tests were conducted for mean differences and Chi-Square analysis for frequencies. A two-tailed significance level was set at 0.05.
      A network structure representing the PeSAS items was estimated through exploratory graph analysis (EGA),
      • Golino HF
      • Epskamp S
      Exploratory graph analysis: A new approach for estimating the number of dimensions in psychological research.
      using the EGA function of the EGAnet package, accessed through R 4.0.0. EGA uses the Gaussian Graphical Model, based on regularized partial correlations which represent the strength of association between each pair of items after associations with all other items have been controlled for. The network contains nodes (symptoms) and edges (associations between symptoms, represented by connecting lines for the partial correlations between symptoms). The network was graphically represented based on the Fruchterman–Reingold algorithm.
      • Epskamp S
      • Borsboom D
      • Fried EI.
      Estimating psychological networks and their accuracy: A tutorial paper.

      Results

      Clinicians

      Clinicians totaling 216 were trained across six services in 2021. They were experienced, mostly nurses, with their disciplines and socio-demographics displayed in Table 2. Significant gains in self-perceived efficacy in screening are shown in Table 3. This growth in confidence achieved an overall Cohen's d = 0.86, a large effect size.
      Table 3Clinician Efficacy in Conducting Psycho-existential Symptom Assessment Scale (PeSAS) Screening Comparing Pre and Post training Confidence Scores Out of 10 for 204 Clinicians Who were Among Attendees at 21 Workshops
      Skills ConfidencePre-training

      Mean (SD)
      Post-training Mean (SD)Change in MeansCohen's D
      Assess physical symptoms7.22 (1.98)7.92 (1.53)0.700.42
      Assess psychological symptoms6.39 (1.71)7.81 (1.11)1.421.01
      Assess existential symptoms5.67 (1.83)7.80 (1.10)2.131.45
      Assess suicidal symptoms5.67 (2.15)7.55 (1.40)1.881.06
      Empathic responsiveness7.16 (1.88)8.23 (1.25)1.070.67
      Diagnose psychiatric disorder4.46 (2.16)6.40 (1.87)1.940.96
      Manage overall distress6.71 (1.71)7.88 (1.23)1.170.80
      Effect referrals when needed7.46 (1.65)8.45 (1.22)0.990.69
      Cohen's D: 0.2 = small effect size, 0.5 = medium effect size, 0.8 = large effect size
      Clinicians rated the usefulness of training (scored of 10) with mean (SD) values for confidence in using the communication skills as 8.7 (1.2), likelihood of better patient care 8.8 (1.2), personal review of their communication 8.6 (1.5), and usefulness of role play 8.5 (1.5).

      Services

      From a total of 1405 patients screened, service A (n = 323 patients screened) had a medical-nursing model; service B (n = 226) had a broader mix of clinicians; service C (n = 49) depended on a nurse champion; service D (n = 625) had a strong psychosocial model; service E (n = 70) used a nurse champion; and service F (n = 112) had a medical-nursing care model. Services A, B and D used software to record PeSAS data; services C, E and F employed pencil and paper.
      Each service's implementation model was flexible in allowing clinicians to gradually develop their skill and confidence, and employ clinical judgement about the incorporation of PeSAS screening into their practice. As a clinician's confidence grew, most clinicians incorporated screening into their initial patient assessments; some deferred it until later patient encounters.

      Patients

      Prevalences of PeSAS scores are grouped into severe (≥8) and moderate (≥4 ≤7), alongside clinically significant (≥4) total scores as displayed in Table 4. Precision of measurement (the difference in 95% confidence intervals) was good, with greater accuracy for severe symptom ratings (precision strong, generally <3%) than moderate or total symptom ratings (precision <5%).
      Table 4Prevalence of Psycho-existential Symptoms Among 1405 Palliative Care Patients in Clinically Significant (≥4), Moderate 4-7 and Severe (≥8) Categories
      Individual PeSASsymptomsSevere ≥8% (95% CI)Moderate 4–7% (95% CI)Clinically Significant ≥4% (95% CI)
      Anxiety8.1 (6.7–9.7)33.0 (30.6–35.6)41.1 (38.6–43.8)
      Discouragement9.9 (8.4–11.6)27.7 (23.4–30.2)37.6 (35.1–40.3)
      Trapped by Illness23.5 (21.3–25.9)30.2 (27.8–32.7)53.7 (51.0–56.4)
      Hopelessness13.1 (11.3–15.0)22.7 (20.5–25.0)35.8 (33.2–38.3)
      Pointlessness9.5 (8.0–11.1)17.4 (15.5–19.6)26.9 (24.6–29.3)
      Loss of Control15.1 (13.3–17.1)33.8 (31.3–36.3)48.9 (46.2–51.6)
      Loss of Roles15.6 (13.7–17.6)29.8 (27.3–32.2)45.4 (42.3–48.0)
      Depression8.6 (7.2–10.2)21.7 (19.5–24.0)30.3 (27.9–32.8)
      Wish to die7.6 (6.2–9.1)9.4 (7.9–11.1)17.0 (15.0–19.1)
      Confused3.6 (2.7–4.8)11.9 (10.2–13.8)15.5 (13.7–17.6)
      To confirm the discriminatory ability of PeSAS, patients with high PESAS scores (≥75th percentile = 41) had significantly lower AKPS scores (M = 49.3, SD = 13.7) than patients with lower PESAS scores (M = 53.2; SD = 14.5) (t-test P < 0.001, d = 0.3). Patients with high PESAS scores were also significantly more likely to be in unstable, deteriorating, or terminal PCOC phases of illness (68.7%) than patients with lower PESAS scores (57.2%) (Chi-Square P = 0.001; adjusted standardized residual = 3.2).
      Patients can choose to omit items if they wish. From 1405 patients, 128 (9%) returned incomplete data. Reasons included that patients can be unsure, hesitant to ascribe a rating value, want to remain private, or prefer to offer a more detailed commentary about their experience than can be portrayed numerically.
      The network of symptoms is depicted graphically in Fig. 2 using exploratory graph analysis. Hopelessness was the central symptom (node), pointlessness was most strongly associated with the wish to die, while feeling trapped (coping) was associated with loss of roles and loss of control. A median network produced from 10,000 bootstrap iterations was highly similar to the original network, providing credence to the network's stability.
      Fig 2
      Fig. 2Exploratory graph analysis of psycho-existential symptoms assessed in 1277 palliative care patients on admission to a clinical service (patients with complete data). The thickness and darkness of interconnecting lines between symptoms reflect the regularized partial correlations, a measure of the strength of association between each pair of symptoms after associations with all other items have been controlled for.
      Standardized centrality values of nodes are displayed in Supplementary Figure 3. Higher levels of centrality suggest greater involvement in the network. In the estimated network, the most central nodes were hopelessness, depression and pointlessness.

      Discussion

      Clinicians unfamiliar with screening for psycho-existential symptoms were trained to implement this in palliative care. As a result of experiential roleplay exercises, they grew significantly in confidence in assessment. Many were surprised by the efficiency possible. They valued the model of screen first, then assess in detail, and plan for management later. Clinicians also appreciated the structured approach in the PeSAS, helping gain a greater understanding of each person.
      The data are noteworthy for the precision involved in prevalence estimates of these symptoms, especially in the severe category. These prevalences are consistent with formal studies of psycho-existential distress.
      • Morita T
      • Kawa M
      • Honke Y
      • et al.
      Existential concerns of terminally ill cancer patients receiving specialized palliative care in Japan.
      • Robinson S
      • Kissane DW
      • Brooker J
      • Burney S
      A systematic review of the Demoralization Syndrome in individuals with progressive disease and cancer: a decade of research.
      • Tecuta L
      • Tomba E
      • Grandi S
      • Fava GA.
      Demoralization: a systematic review on its clinical characterization.
      • Tang PL
      • Wang HH
      • Chou FH.
      A systematic review and meta-analysis of demoralization and depression in patients with cancer.
      • Gan LL
      • Gong S
      • Kissane DW.
      Mental state of demoralisation across diverse clinical settings: A systematic review, meta-analysis and proposal for its use as a ‘specifier’ in mental illness.
      Around one half of patients felt trapped by their illness, a clear signifier of distress. Loss of control over their life and loss of roles (career, partner, parent) were also prominent. Demoralization occurred in one third of patients, with symptoms of discouragement, hopelessness and pointlessness of life proving prominent. States of anxiety and depression also featured in many, while the wish to die was severe in 7.6% and moderate in 9.4%, consistent with clinical practice.
      Patients are free to decline an item response and 9% of our participants returned incomplete screening data. Openness is dependent on a trusting clinician-patient relationship, which can be established over time. Masking of distress can also result from a somatizing or alexithymic style, defensive coping mechanisms, shame or fear of stigma over revealing psychological distress or a lack of trust in the clinician. However, the majority of patients express relief when they feel well understood by a compassionate clinician who has inquired about dimensions of their suffering that others have avoided.
      The network map based on the strength of associations between these symptoms confirmed the centrality of hopelessness,
      • Belvederi Murri M
      • Caruso R
      • Ounalli H
      • et al.
      The relationship between demoralization and depressive symptoms among patients from the general hospital: network and exploratory graph analysis.
      ,
      • Bobevski I
      • Kissane DW
      • Vehling S
      • Mehnert-Theuerkauf A
      • Belvederi Murri M
      • Grassi L
      Demoralization and its link with depression, psychological adjustment and suicidality among cancer patients: A network psychometrics approach.
      the way pointlessness is the key driver of the wish to die, the links between poor coping (feeling trapped) and loss of control and roles, and the quadratic relationship between anxiety, discouragement, depression and hopelessness. Therapeutic strategies to restore hope and meaning are central alongside management of anxiety and depression.
      Implementation research was adapted to each site and the local problems that arose,
      • Glasgow RE
      • Vinson C
      • Chambers D
      • Khoury MJ
      • Kaplan RM
      • Hunter C.
      National Institutes of Health approaches to dissemination and implementation science: current and future directions.
      ,
      • Tabak RG
      • Khoong EC
      • Chambers DA
      • Brownson RC.
      Bridging research and practice: models for dissemination and implementation research.
      inclusive of Covid-19 lockdowns. Use of an implementation committee, engagement of site leadership, electronic recording of PeSAS and local champions proved helpful. Services employing real-time electronic PeSAS entry did best. When a site's physician leader was less involved (e.g., services C and E), trainee physicians bypassed screening. When a biomedical and pharmacological orientation prevailed, introduction of PeSAS was slower (e.g., service F). One service committed their psychosocial staff to take responsibility (service D) with their uptake most successful. Other services had fewer psychosocial staff, depending instead on nurses. When nurse specialists/practitioners worked independently in the community (e.g., services A and B), their appreciation of the importance of psycho-existential distress reflected their wisdom as clinicians.
      By comparing services, we could gradually “wake up” institutions to appreciate any historical neglect of psycho-existential issues. This dialectical process in implementation work has been well described,
      • Kitson AL
      • Rycroft-Malone J
      • Harvey G
      • et al.
      Evaluating the successful implementation of evidence into practice using the PARiHS framework: theoretical and practical challenges.
      necessitated much nurturance, and succeeded better in services that were more psychosocially attuned.
      There are strengths and limitations to this study. Limitations include the cross-sectional nature of this report; its focus on service issues and clinical processes rather than patient outcomes over time; the complexity of system change with its action research model; lack of generalizability across diverse services; challenges with non-electronic data collection; and the lack of a controlled trial. Implementation research has a practical, real-world orientation, which can be derailed by extensive data collection rather than a focus on services and clinical processes.
      • Glasgow RE
      • Vinson C
      • Chambers D
      • Khoury MJ
      • Kaplan RM
      • Hunter C.
      National Institutes of Health approaches to dissemination and implementation science: current and future directions.
      Future work will focus on program maintenance with longitudinal data published next. Nevertheless, the prevalence of psycho-existential distress found in these patients was noteworthy. This work extends the broad distress screening programs
      • Sun H
      • Thapa S
      • Wang B
      • Fu X
      • Yu S.
      A systematic review and meta-analysis of the Distress Thermometer for screening distress in Asian patients with cancer.
      that many cancer services have introduced with a symptom assessment tool that is specific for palliative care. The study's value is its description of an implementation program for palliative care, where studies of a systematic approach to quality care improvement for psycho-existential distress have been few.

      Conclusion

      This implementation of a routine psycho-existential screening tool has identified distress in over one third of the patients screened. Clinicians can be successfully trained to screen in this manner. Real-time electronic entry of symptom data is most valuable. Attention to psycho-existential suffering in palliative care is clearly warranted.

      Disclosures and Acknowledgments

      The authors have nothing to declare. Australian Commonwealth Department of Health Palliative Care National Program grant number 4-E1QGPW9 awarded to David W Kissane
      The authors thank the staff who helped with this project, especially Antonio Claridad, Danielle Carboon, Rachel Eade, Nicholas Glasgow, Nicola Lowrie, Jessica Mather-Hillon, Cynthia Masters, Graham Moss, Nicole Tait, and Grace Walpole.

      Appendix. Supplementary materials

      References

        • Kissane DW
        Education and assessment of psycho-existential symptoms to prevent suicidality in cancer care.
        Psychooncology. 2020; 29https://doi.org/10.1002/pon.5519
        • Vehling S
        • Kissane DW.
        Existential distress in cancer: Alleviating suffering from fundamental loss and change.
        Psychooncology. 2018; 27: 2525-2530https://doi.org/10.1002/pon.4872
        • Walker J
        • Holm Hansen C
        • Martin P
        • et al.
        Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.
        Lancet Psychiatry. 2014; (published online Aug 28)https://doi.org/10.1016/S2215-0366(14)70313-X
        • Kissane DW
        Unrecognized and untreated depression in cancer care.
        Lancet Psychiatry. 2014; 1: 320-321https://doi.org/10.1016/S2215-0366(14)70345-1
        • Jacobsen PB
        • Donovan KA
        • Trask PC
        • et al.
        Screening for psychologic distress in ambulatory cancer patients.
        Cancer. 2005; 103: 1494-1502https://doi.org/10.1002/cncr.20940
        • Holland JC
        • Bultz BD.
        National Comprehensive Cancer Network (NCCN). The NCCN guideline for distress management: a case for making distress the sixth vital sign.
        J National Comprehensive Cancer Network. 2007; 5: 3-7https://doi.org/10.6004/jnccn.2007.0003
        • Fashoyin-Aje LA
        • Martinez KA
        • Dy SM.
        New patient-centered care standards from the Commission on Cancer: opportunities and challenges.
        J Support Oncol. 2012; 10: 107-111https://doi.org/10.1016/j.suponc.2011.12.002
        • Lazenby M
        • Ercolano E
        • Grant M
        • et al.
        Supporting Commission on Cancer-mandated psychosocial distress screening with implementation strategies.
        J Oncol Pract. 2015; 11 (Available at:): e413-e420
        • Lazenby M
        • Ercolano E
        • Knies A
        • et al.
        Psychosocial distress screening: an educational program's impact on participants’ goals for screening implementation in routine cancer care.
        Clin J Oncol Nurs. 2018; 22: e85-e91https://doi.org/10.1188/18.CJON.E85-E91
        • Graham-Wisener L
        • Dempster M
        • Sadler A
        • et al.
        Validation of the Distress Thermometer in patients receiving specialist palliative care in a hospice setting.
        Palliat Med. 2021; 35: 120-129https://doi.org/10.1177/0269216320954339
        • Clover KA
        • Oldmeadow C
        • Nelson L
        • et al.
        Which items on the distress thermometer problem list are the most distressing?.
        Supportive Care Cancer. 2016; 24: 4549-4557https://doi.org/10.1007/s00520-016-3294-z
        • Bruera E
        • Kuehn N
        • Miller MJ
        • Selmser P
        • Macmillan K.
        The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients.
        J Palliative Care. 1991; 7: 6-9https://doi.org/10.1177/082585979100700202
        • Hui D
        • Bruera E.
        The Edmonton Symptom Assessment System 25 years later: past, present and future developments.
        J Pain Symptom Management. 2017; 53: 630-643https://doi.org/10.1016/j.jpainsymman.2016.10.370
        • Agar K
        • Watters P
        • Currow DC
        • Aoun SM
        • Yates P.
        The Australian Palliative Care Outcomes Collaboration (PCOC) – measuring the quality and outcomes of palliative care on a routine basis.
        Aust Health Rev. 2010; 34: 186-192https://doi.org/10.1071/AH08718
        • Daveson BA
        • Allingham SF
        • Clapham S
        • et al.
        The PCOC Symptom Assessment Scale (SAS): a valid measure for daily use at point of care and in palliative care programs.
        PLoS One. 2021; 16e0247250https://doi.org/10.1371/journal.pone.0247250
        • Aslakson RA
        • Dy SM
        • Wilson RF
        • et al.
        Patient- and caregiver-reported assessment tools for palliative care: summary of the 2017 Agency for Healthcare Research and Quality Technical Brief.
        J Pain Symptom Manage. 2017; 54: 961-972https://doi.org/10.1016/j.jpainsymman.2017.04.022
        • Cohen SR
        • Mount BM
        • Tomas JJ
        • Mount LF.
        Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire.
        Cancer. 1996; 77: 576-586https://doi.org/10.1002/(SICI)1097-0142(19960201)77::3≤576:AID-CNCR22≥3.0.CO;2-0
        • Kissane DW
        Demoralization – A life-preserving diagnosis to make in the severely medically ill.
        J Palliative Care. 2014; 30 (PMID: 25962256): 255-258
        • Robinson S
        • Kissane DW
        • Brooker J
        • Burney S.
        A review of the construct of demoralization: history, definitions, and future directions for palliative care.
        American J Hospice Palliative Medicine. 2016; 33: 93-101https://doi.org/10.1177/1049909114553461
        • Morita T
        • Kawa M
        • Honke Y
        • et al.
        Existential concerns of terminally ill cancer patients receiving specialized palliative care in Japan.
        Support Care Cancer. 2004; 12: 137-140https://doi.org/10.1007/s00520-003-0561-6
        • Robinson S
        • Kissane DW
        • Brooker J
        • Burney S
        A systematic review of the Demoralization Syndrome in individuals with progressive disease and cancer: a decade of research.
        J Pain Symptom Management. 2015; 49: 595-610https://doi.org/10.1016/j.jpainsymman
        • Tecuta L
        • Tomba E
        • Grandi S
        • Fava GA.
        Demoralization: a systematic review on its clinical characterization.
        Psychol Med. 2015; 45: 673-691https://doi.org/10.1017/S0033291714001597
        • Tang PL
        • Wang HH
        • Chou FH.
        A systematic review and meta-analysis of demoralization and depression in patients with cancer.
        Psychosomatics. 2015; 56: 634-643https://doi.org/10.1016/j.psym.2015.06.005
        • Gan LL
        • Gong S
        • Kissane DW.
        Mental state of demoralisation across diverse clinical settings: A systematic review, meta-analysis and proposal for its use as a ‘specifier’ in mental illness.
        Australian New Zealand J Psychiatry. 2021; : 1-26https://doi.org/10.1177/00048674211060746
        • Kissane DW
        • Wein S
        • Love A
        • Lee XQ
        • Kee PL
        • Clarke DM.
        The Demoralization Scale: a preliminary report of its development and preliminary validation.
        J Palliative Care. 2004; 20 (PMID: 15690829): 269-276
        • Robinson S
        • Kissane DW
        • Brooker J
        • et al.
        Refinement and revalidation of the Demoralization Scale: the DS-II ‒ internal validity.
        Cancer. 2016; 122: 2251-2259https://doi.org/10.1002/cncr.30015
        • Robinson S
        • Kissane DW
        • Brooker J
        • et al.
        Refinement and revalidation of the Demoralization Scale: the DS-II ‒ external validity.
        Cancer. 2016; 122: 2260-2267https://doi.org/10.1002/cncr.30012/pdf
        • Belvederi Murri M
        • Zerbinatia L
        • Ounallia H
        • et al.
        Assessing demoralization in medically ill patients: Factor structure of the Italian version of the demoralization scale and development of short versions with the item response theory framework.
        J Psychosomatic Research. 2020; 128109889https://doi.org/10.1016/j.jpsychores.2019.109889
      1. Bobevski I, Kissane DW, McKenzie D, et al. The Demoralization Interview: reliability and validity of a new brief diagnostic measure. Under review

        • Fava GA
        • Freyberger HJ
        • Bech P
        • et al.
        Diagnostic criteria for use in psychosomatic research.
        Psychother Psychosom. 1995; 63: 1-8https://doi.org/10.1159/000288931
        • Bobevski I
        • Kissane DW
        • Vehling S
        • McKenzie D
        • Glaesmer H
        • Mehnert A.
        Latent class analysis differentiation of adjustment disorder and demoralization, more severe depressive-anxiety disorders, and somatic symptoms in a cohort of patients with cancer.
        Psychooncology. 2018; 27: 2623-2630https://doi.org/10.1002/pon.4761
        • Belvederi Murri M
        • Caruso R
        • Ounalli H
        • et al.
        The relationship between demoralization and depressive symptoms among patients from the general hospital: network and exploratory graph analysis.
        J Affective Disorders. 2020; 276: 137-146https://doi.org/10.1016/j.jad.2020.06.074
        • Bobevski I
        • Kissane DW
        • Vehling S
        • Mehnert-Theuerkauf A
        • Belvederi Murri M
        • Grassi L
        Demoralization and its link with depression, psychological adjustment and suicidality among cancer patients: A network psychometrics approach.
        Cancer Med. 2021; 00: 1-11https://doi.org/10.1002/cam4.4406
        • Glasgow RE
        • Vinson C
        • Chambers D
        • Khoury MJ
        • Kaplan RM
        • Hunter C.
        National Institutes of Health approaches to dissemination and implementation science: current and future directions.
        Am J Public Health. 2012; 102: 1274-1281https://doi.org/10.2105/AJPH.2012.300755
        • Tabak RG
        • Khoong EC
        • Chambers DA
        • Brownson RC.
        Bridging research and practice: models for dissemination and implementation research.
        Am J Preventive Medicine. 2012; 43: 337-350https://doi.org/10.1016/j.amepre.2012.05.024
        • Abernethy AP
        • Shelby-James T
        • Fazekas BS
        • Woods D
        • Currow DC
        The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481].
        BMC Palliative Care. 2005; 4: 7https://doi.org/10.1186/1472-684X-4-7
        • Golino HF
        • Epskamp S
        Exploratory graph analysis: A new approach for estimating the number of dimensions in psychological research.
        PLoS One. 2017; 12e0174035https://doi.org/10.1371/journal.pone.0174035
        • Epskamp S
        • Borsboom D
        • Fried EI.
        Estimating psychological networks and their accuracy: A tutorial paper.
        Behav Res Methods. 2018; 50: 195-212https://doi.org/10.3758/s13428-017-0862-1
        • Kitson AL
        • Rycroft-Malone J
        • Harvey G
        • et al.
        Evaluating the successful implementation of evidence into practice using the PARiHS framework: theoretical and practical challenges.
        Implementation Science. 2008; 3: 1-12https://doi.org/10.1186/1748-5908-3-1
        • Sun H
        • Thapa S
        • Wang B
        • Fu X
        • Yu S.
        A systematic review and meta-analysis of the Distress Thermometer for screening distress in Asian patients with cancer.
        J Clinical Psychological and Medical Settings. 2021; 28: 212-220https://doi.org/10.1007/s10880-020-09705-9